Managing major depressive disorder in adolescents in primary care

JAAPA. 2024 May 1;37(5):15-21. doi: 10.1097/01.JAA.0000000000000003. Epub 2024 Apr 25.

Abstract

Major depressive disorder (MDD) remains a significant risk to adolescent health and well-being, recently amplified by the COVID-19 pandemic. Access to adolescent mental health care services remains challenging in many areas, resulting in many adolescents diagnosed with MDD remaining untreated. Primary care providers are becoming increasingly crucial in promptly diagnosing and treating this concern. Various clinical guidelines can support clinicians in developing strategies for screening, diagnosing, and managing a vulnerable population with MDD. Standardized screenings, algorithms, and treatment guidelines can help improve the quality of life and functional impairment of those with MDD.

MeSH terms

  • Adolescent
  • Antidepressive Agents / therapeutic use
  • COVID-19* / epidemiology
  • COVID-19* / therapy
  • Depressive Disorder, Major* / diagnosis
  • Depressive Disorder, Major* / therapy
  • Female
  • Humans
  • Male
  • Mental Health Services
  • Pandemics
  • Practice Guidelines as Topic
  • Primary Health Care*
  • Quality of Life
  • SARS-CoV-2

Substances

  • Antidepressive Agents